CCR2 and myeloid sarcoma: No significant difference between MS patients and non-inflammatory controls were found in some studies regarding CCR2 expression on monocytes or T cells [54,55], while in other studies expression of CCR2 on circulating monocytes was demonstrated during MS relapse [56].